<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02999932</url>
  </required_header>
  <id_info>
    <org_study_id>WuhanUHICU201701</org_study_id>
    <nct_id>NCT02999932</nct_id>
  </id_info>
  <brief_title>Pulse Oxygen Saturation (SpO2) Directed Oxygen Therapy</brief_title>
  <acronym>POSDOT</acronym>
  <official_title>Effect of Low vs High Pulse Oxygen Saturation (SpO2) Directed Oxygen Therapy on Mortality Among Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wu Jieping Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators hypothesized that a relative low SpO2 directed oxygen therapy would reduced the
      mortality in patients staying longer than 72 hours in ICUs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In fear of harmful effect of hypoxia, oxygen therapy is commonly used, especially in
      critically ill patients in intensive care units (ICUs). However, hyperoxia can be harmful
      too. Examples are myocardial infarction (MI) patients and patients resuscitated to return of
      spontaneous circulation after cardiac arrest. In Air Versus Oxygen in Myocardial Infarction
      (AVOID) trial, Meyhoff and colleagues proved hyperoxia caused more cardiac injury in patients
      with ST-elevation MI but without hypoxia. Kilgannon and colleagues found that arterial
      hyperoxia following resuscitation from cardiac arrest were associated with increased
      in-hospital mortality, and a pulse oxygen saturation (SpO2) of 94-98% was recommended.

      Recently, Panwar and colleagues found that compared to liberal oxygen strategy (SpO2 ≥96%),
      conservative oxygen strategy (SpO2 of 88%-92%) was feasible in patients receiving invasive
      mechanical ventilation. Girardis and colleagues found control oxygen therapy (targeting SpO2
      of 94%-98% or PaO2 of 70-100mmHg) resulted lower ICU mortality than conventional oxygen
      therapy (SpO2 ≥97%) in the randomized clinical trial called Oxygen-ICU. However, the
      Oxygen-ICU trial was single-centered, early-terminated with only 480 patients included and
      led to an unplanned interim analysis. In this larger multicenter trial, investigators
      hypothesized that a relative low SpO2 directed oxygen therapy was safe and would reduced the
      28-day mortality in patients staying longer than 72 hours in ICUs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28-day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mordified ICU mortality</measure>
    <time_frame>through ICU stay and 24 hours after discharged from ICU, an average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilator free time</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal replacement therapy free time</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2148</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Low SpO2 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SpO2 90-95%, with FiO2 as low as possible.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High SpO2 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SpO2 96-100%, with FiO2 no lower than 30%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SpO2 directed oxygen therapy</intervention_name>
    <description>Oxygen therapy was administered to achieve targeted SpO2.</description>
    <arm_group_label>High SpO2 group</arm_group_label>
    <arm_group_label>Low SpO2 group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18 years or older and admitted into ICU, with expected stay in ICU more than 72
             hours or longer.

        Exclusion Criteria:

          -  under 18 years old, expected stay in ICU less than 72 hours, unconsented inclusion,
             ICU readmission, patients with acute exacerbation of chronic obstruction disease,
             patients with severe acute respiratory distress syndrome (defined as PaO2/FiO2 ≤
             100mmHg and PEEP ≥10cmH2O), decision to withhold life-sustaining treatment, physician
             forgetting to screen during 12 hours after admission, pregnancy, patients with acute
             myocardial infarction, paraquat poisoning and patients on extracorporeal membrane
             oxygenation (ECMO) or planned to be on ECMO.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiying Yuan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Wuhan Union Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shiying Yuan, MD</last_name>
    <phone>+8613607145351</phone>
    <email>yuan_shiying@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaobo Yang, MD</last_name>
    <phone>+8613720311349</phone>
    <email>want.tofly@aliyun.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of critical care medicine，Luoyang Central Hospital Affiliated to ZhengZhou University</name>
      <address>
        <city>Luoyang</city>
        <state>Henan</state>
        <zip>471000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keke Xin, MD</last_name>
      <phone>13838411360</phone>
      <email>lypfxkk@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine，Xinyang Central Hospital</name>
      <address>
        <city>Xinyang</city>
        <state>Henan</state>
        <zip>464000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yubao Sun, MD</last_name>
      <phone>15649150597</phone>
      <email>yubaosun6616@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuan Shi, MD</last_name>
      <phone>15037190102</phone>
      <email>15037190102@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongbin Li, MD</last_name>
      <phone>13598855561</phone>
      <email>lihongbin2006@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine，Zhengzhou Central Hospital Affiliated to Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450007</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yueli Peng, MD</last_name>
      <phone>13607648955</phone>
      <email>175296238@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, Renmin Hospital of Shiyan City</name>
      <address>
        <city>Shiyan</city>
        <state>Hubei</state>
        <zip>442000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu Zhao, MD</last_name>
      <phone>13429965677</phone>
      <email>124874549@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, Taihe Hospital</name>
      <address>
        <city>Shiyan</city>
        <state>Hubei</state>
        <zip>442000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Chen, MD</last_name>
      <phone>18671918088</phone>
      <email>6894935@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, The Central Hospital of Wuhan</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanli Liu, MD</last_name>
      <phone>13476865152</phone>
      <email>175458285@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiying Yuan, MD</last_name>
      <phone>+8613607145351</phone>
      <email>yuan_shiying@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine，Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lizhi Feng, MD</last_name>
      <phone>15997479071</phone>
      <email>873976675@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit, Hubei Cancer Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430079</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronghua Hu, MD</last_name>
      <phone>18627800775</phone>
      <email>13396062017@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, Xiangyang No.1 People's Hospital, Affiliated Hospital of Hubei University of Medicine</name>
      <address>
        <city>Xiangyang</city>
        <state>Hubei</state>
        <zip>441000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhengqin Xu, MD</last_name>
      <phone>13339809727</phone>
      <email>53655752@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of critical care medicine, XiangYang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science</name>
      <address>
        <city>Xiangyang</city>
        <state>Hubei</state>
        <zip>441021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lu Zhang, MD</last_name>
      <phone>13487117277</phone>
      <email>725703@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
  </removed_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>December 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2016</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Xiaobo Yang, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

